Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Journal of Translational Medicine
|
April 12, 2022
Cisplatin resistance-related multi-omics differences and the establishment of machine learning models
Qihai Sui, Zhencong Chen, Zhengyang Hu, et al.
Cell Reports
|
February 9, 2024
Transcription factor ZNF263 enhances EGFR-targeted therapeutic response and reduces residual disease in lung adenocarcinoma
Jiaqi Liang, Guoshu Bi, Qihai Sui, et al.
Frontiers in Molecular Biosciences
|
December 16, 2020
The Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers
Tengteng Wei, Guoshu Bi, Yunyi Bian, et al.
Redox Biology
|
September 24, 2024
Targeting ALDH1A1 to enhance the efficacy of KRAS-targeted therapy through ferroptosis
Yunyi Bian, Guangyao Shan, Guoshu Bi, et al.
Peerj
|
March 16, 2023
HNF4G increases cisplatin resistance in lung adenocarcinoma via the MAPK6/Akt pathway
Jiaqi Liang, Guangyin Zhao, Yunyi Bian, et al.
Cancer Letters
|
October 1, 2025
Targeting inosine metabolism to enhance EGFR-targeted therapy in lung adenocarcinoma
Xiaolong Huang, Jiaqi Liang, Yanjun Yi, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
October 12, 2022
FSCN1 induced PTPRF-dependent tumor microenvironment inflammatory reprogramming promotes lung adenocarcinoma progression via regulating macrophagic glycolysis
Yiwei Huang, Guangyao Shan, Yanjun Yi, et al.
Cancer Immunology, Immunotherapy : CII
|
November 27, 2021
Metformin inhibits human non-small cell lung cancer by regulating AMPK-CEBPB-PDL1 signaling pathway
Tao Lu, Ming Li, Mengnan Zhao, et al.
Cancer Research
|
May 15, 2023
Retinol Saturase Mediates Retinoid Metabolism to Impair a Ferroptosis Defense System in Cancer Cells
Guoshu Bi, Jiaqi Liang, Guangyao Shan, et al.
Cell Discovery
|
October 7, 2025
Ferroptosis-induced SUMO2 lactylation counteracts ferroptosis by enhancing ACSL4 degradation in lung adenocarcinoma
Guangyao Shan, Yunyi Bian, Qihai Sui, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Journal of Translational Medicine
|
April 12, 2022
Cisplatin resistance-related multi-omics differences and the establishment of machine learning models
Qihai Sui, Zhencong Chen, Zhengyang Hu, et al.
Cell Reports
|
February 9, 2024
Transcription factor ZNF263 enhances EGFR-targeted therapeutic response and reduces residual disease in lung adenocarcinoma
Jiaqi Liang, Guoshu Bi, Qihai Sui, et al.
Frontiers in Molecular Biosciences
|
December 16, 2020
The Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers
Tengteng Wei, Guoshu Bi, Yunyi Bian, et al.
Redox Biology
|
September 24, 2024
Targeting ALDH1A1 to enhance the efficacy of KRAS-targeted therapy through ferroptosis
Yunyi Bian, Guangyao Shan, Guoshu Bi, et al.
Peerj
|
March 16, 2023
HNF4G increases cisplatin resistance in lung adenocarcinoma via the MAPK6/Akt pathway
Jiaqi Liang, Guangyin Zhao, Yunyi Bian, et al.
Cancer Letters
|
October 1, 2025
Targeting inosine metabolism to enhance EGFR-targeted therapy in lung adenocarcinoma
Xiaolong Huang, Jiaqi Liang, Yanjun Yi, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
October 12, 2022
FSCN1 induced PTPRF-dependent tumor microenvironment inflammatory reprogramming promotes lung adenocarcinoma progression via regulating macrophagic glycolysis
Yiwei Huang, Guangyao Shan, Yanjun Yi, et al.
Cancer Immunology, Immunotherapy : CII
|
November 27, 2021
Metformin inhibits human non-small cell lung cancer by regulating AMPK-CEBPB-PDL1 signaling pathway
Tao Lu, Ming Li, Mengnan Zhao, et al.
Cancer Research
|
May 15, 2023
Retinol Saturase Mediates Retinoid Metabolism to Impair a Ferroptosis Defense System in Cancer Cells
Guoshu Bi, Jiaqi Liang, Guangyao Shan, et al.
Cell Discovery
|
October 7, 2025
Ferroptosis-induced SUMO2 lactylation counteracts ferroptosis by enhancing ACSL4 degradation in lung adenocarcinoma
Guangyao Shan, Yunyi Bian, Qihai Sui, et al.
Page
of 8